Table 7 Tumor staging before and after letrozole treatment (Safety population (N = 32), number and percentage of patients)
Clinical stage | Baseline | Individual End |
|---|---|---|
T1a | -- | 1 (3.1%) |
T1b | -- | 1 (3.1%) |
T1c | -- | 7 (21.9%) |
T2 | 23 (71.9%) | 19 (59.4%) |
T3 | 5 (15.6%) | -- |
T4a | 1 (3.1%) | -- |
T4b | 3 (9.4%) | -- |
Missing | -- | 4 (12.5%) |